Readability Analysis of the Package Leaflets for Biological Medicines Available on the Internet Between 2007 and 2013: An Analytical Longitudinal Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Works matching DE "DRUG labeling laws"
Results: 57
1
2
Too Good To Last? Will the FDA'S Proposed Rule Put an End to Generic Drug Preemption Under Mensing and Bartlett?
- Published in:
- Defense Counsel Journal, 2015, v. 82, n. 1, p. 28, doi. 10.12690/IADC-15-002
- By:
- Publication type:
- Article
3
An Update on FDA Preemption of State Law Claims.
- Published in:
- Defense Counsel Journal, 2007, v. 74, n. 1, p. 81
- By:
- Publication type:
- Article
4
Inventing Drugs: A Genealogy of a Regulatory Concept.
- Published in:
- Journal of Law & Society, 2016, v. 43, n. 3, p. 393, doi. 10.1111/j.1467-6478.2016.00760.x
- By:
- Publication type:
- Article
5
Information on codeine.
- Published in:
- Anaesthesia, 2001, v. 56, n. 12, p. 1203, doi. 10.1046/j.1365-2044.2001.02369-22.x
- By:
- Publication type:
- Article
6
Ephedrine/Epinephrine drug label confusion.
- Published in:
- Anaesthesia, 1998, v. 53, n. 5, p. 511, doi. 10.1046/j.1365-2044.1998.04771.x
- By:
- Publication type:
- Article
7
THE WEATHERVANE.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
8
Relevance of variation in use of terminology to define generic pharmaceutical products.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2015, v. 37, n. 2, p. 113
- By:
- Publication type:
- Article
9
Proposed FDA Generic Drug Labeling Policy Questioned.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 10, p. 1005, doi. 10.1001/jama.2014.1175
- By:
- Publication type:
- Article
10
Medicines labelling.
- Published in:
- Australian Prescriber, 2011, v. 34, n. 5, p. 136, doi. 10.18773/austprescr.2011.072
- By:
- Publication type:
- Article
11
A First Amendment Approach to Generic Drug Manufacturer Tort Liability.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
12
12 ANGRY MEN V. THE AGENCY: WHY PREEMPTION SHOULD RESOLVE THIS CONFLICT IN DRUG LABELING LITIGATION.
- Published in:
- Marquette Law Review, 2017, v. 100, n. 4, p. 1309
- By:
- Publication type:
- Article
13
A Decision Analysis Model to Justify and Approve Off-Label Drug Use in Pain and Palliative Care.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
14
Medication Safety and Reliability. Lopinavir/ritonavir label change warns of serious risks in premature babies.
- Published in:
- Formulary, 2011, v. 46, n. 4, p. 147
- Publication type:
- Article
15
Medication Safety and Reliability. FDA warns of risks associated with the use of antipsychotic medications in pregnancy.
- Published in:
- Formulary, 2011, v. 46, n. 4, p. 147
- Publication type:
- Article
16
Medication Safety and Reliability. Pediatric OTC liquids found to have variable and inconsistent dosing directions and measuring devices.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 29
- Publication type:
- Article
17
An update on drug-drug interactions with biologics for the treatment of moderate-to-severe psoriasis.
- Published in:
- Journal of Dermatological Treatment, 2014, v. 25, n. 1, p. 87, doi. 10.3109/09546634.2013.825041
- By:
- Publication type:
- Article
18
FDA sets geriatric drug use labeling deadlines.
- Published in:
- JAMA: Journal of the American Medical Association, 1997, v. 278, n. 16, p. 1302, doi. 10.1001/jama.1997.03550160022010
- By:
- Publication type:
- Article
19
Provision of prescription drug info mandated.
- Published in:
- JAMA: Journal of the American Medical Association, 1996, v. 276, n. 12, p. 935, doi. 10.1001/jama.1996.03540120013006
- By:
- Publication type:
- Article
20
From the Food and Drug Administration.
- Published in:
- 1994
- By:
- Publication type:
- journal article
21
Country-of-origin labels.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 12, p. 1323, doi. 10.1038/nbt1208-1323a
- By:
- Publication type:
- Article
22
An overview of upcoming changes in pregnancy and lactation labeling information.
- Published in:
- Pharmacy Practice (1886-3655), 2015, v. 13, n. 2, p. 1, doi. 10.18549/PharmPract.2015.02.605
- By:
- Publication type:
- Article
23
JURISDICTION -- FEDERAL PRE-EMPTION -- STATE FAILURE-TO-WARN CLAIM NOT PRE-EMPTED BY COMPLIANCE WITH FEDERAL GOVERNMENT DRUG REGULATIONS. Wyeth v. Levine, 129 S. Ct. 1187 (2009).
- Published in:
- Cumberland Law Review, 2009, v. 40, n. 1, p. 321
- By:
- Publication type:
- Article
24
Herbs and Dietary Supplements in the European Union: A Review of the Regulations with Special Focus on Germany and Poland.
- Published in:
- Journal of Dietary Supplements, 2011, v. 8, n. 1, p. 43, doi. 10.3109/19390211.2010.547243
- By:
- Publication type:
- Article
25
A DOSE OF REALITY: THE DEADLY TRUTH ABOUT FEDERAL PREEMPTION OF GENERIC DRUG MANUFACTURER LIABILITY.
- Published in:
- Widener Law Journal, 2015, v. 24, n. 2, p. 355
- By:
- Publication type:
- Article
26
Can the recent public notice by the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy be helpful in combating the irrational use of herbal drugs?
- Published in:
- Journal of Family Medicine & Primary Care, 2016, v. 5, n. 3, p. 732, doi. 10.4103/2249-4863.197286
- By:
- Publication type:
- Article
27
From the Food and Drug Administration.
- Published in:
- 1991
- By:
- Publication type:
- journal article
28
Antipsychotic drugs update: newborns.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 245
- Publication type:
- Article
29
The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 4, p. 459, doi. 10.1177/1060028020956658
- By:
- Publication type:
- Article
30
Off-Label Drug Promotion and the Use of Disclaimers.
- Published in:
- Texas Law Review, 2013, v. 92, n. 1, p. 231
- By:
- Publication type:
- Article
31
New FDA pregnancy drug categories: a significant improvement.
- Published in:
- Contemporary OB/GYN, 2015, v. 60, n. 2, p. 6
- By:
- Publication type:
- Article
32
Warning labels: The role of expertise and perceived risk...
- Published in:
- Health Marketing Quarterly, 1995, v. 13, n. 2, p. 99
- By:
- Publication type:
- Article
33
Forum.
- Published in:
- Pharmaceutical Medicine, 2008, v. 22, n. 4, p. 251, doi. 10.1007/BF03256710
- Publication type:
- Article
34
Regulations on Drug Insert Sheets and Package Labels.
- Published in:
- Chinese Law & Government, 2016, v. 48, n. 4, p. 320, doi. 10.1080/00094609.2016.1118317
- Publication type:
- Article
35
US Supreme Court decisions could affect prescribing practices.
- Published in:
- Contemporary OB/GYN, 2011, v. 56, n. 9, p. 17
- By:
- Publication type:
- Article
36
Trimming the Fat: A Study of Mandatory Nutritional Disclosure Laws and Excessive Judicial Deference.
- Published in:
- Washington & Lee Law Review, 2010, v. 67, n. 2, p. 787
- By:
- Publication type:
- Article
37
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2014, v. 25, n. 1, p. 8
- Publication type:
- Article
38
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2008, v. 19, n. 11, p. 8
- Publication type:
- Article
39
FDA guidance on off-label promotion may be inadequate.
- Published in:
- Brown University Psychopharmacology Update, 2008, v. 19, n. 8, p. 7
- By:
- Publication type:
- Article
40
FDA safety efforts target counterfeiting, unapproved products, and confusing abbreviations; enrollment in Medicare Part D rises above 38 million.
- Published in:
- Formulary, 2006, v. 41, n. 7, p. 354
- By:
- Publication type:
- Article
41
PRAGMATISM, PATERNALISM, AND THE CONSTITUTIONAL PROTECTION OF COMMERCIAL SPEECH.
- Published in:
- Vermont Law Review, 2013, v. 37, n. 3, p. 527
- By:
- Publication type:
- Article
42
Changes coming to pregnancy labeling.
- Published in:
- American Journal of Health-System Pharmacy, 2015, v. 72, n. 3, p. 175, doi. 10.2146/news150008
- By:
- Publication type:
- Article
43
FDA defends generic drug labeling plan.
- Published in:
- American Journal of Health-System Pharmacy, 2014, v. 71, n. 10, p. 770, doi. 10.2146/news140035
- By:
- Publication type:
- Article
44
Pharmacists' role in facilitating evidence-based prescribing for unlabeled use of medications.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
45
Ottawa passes drug safety law.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2014, v. 186, n. 11, p. 818, doi. 10.1503/cmaj.109-4834
- By:
- Publication type:
- Article
46
Laws Promote Pediatric Drug Development.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 296, n. 3, p. 271, doi. 10.1001/jama.296.3.271
- By:
- Publication type:
- Article
47
Drug Package Inserts Get Mixed Reception.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 10, p. 1110, doi. 10.1001/jama.295.10.1110
- By:
- Publication type:
- Article
48
AAFP News: AFP Edition.
- Published in:
- American Family Physician, 2015, v. 92, n. 4, p. 250
- Publication type:
- Article
49
MEDICATION SAFETY.
- Published in:
- Journal of Pharmacy Practice & Research, 2011, v. 41, n. 3, p. 227
- Publication type:
- Article
50
MUTUAL PHARMACEUTICAL CO. V. BARTLETT AND THE DEMISE OF RECOVERY FOR CONSUMERS OF GENERIC DRUGS.
- Published in:
- Loyola Law Review, 2014, v. 60, n. 2, p. 399
- By:
- Publication type:
- Article